Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2021-04-13 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자 결정). It includes detailed terms of the issuance, such as the number of shares, pricing, conversion rights, and call options for third-party allocation. This is a formal regulatory filing regarding capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-04-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, conversion rights, put/call options, and the list of investors. This falls under capital structure changes and financing activities, which is classified as 'CAP' (Capital/Financing Update).
2021-04-09 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from a South Korean company, specifically detailing a decision regarding a paid-in capital increase (유상증자결정) through third-party allocation. This type of filing is a standard regulatory disclosure in the Korean market (DART system) concerning capital structure changes and share issuance. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues and capital changes.
2021-04-09 Korean
조회공시요구(현저한시황변동)에대한답변(미확정)
Regulatory Filings Classification · 95% confidence The document is a response to a regulatory inquiry from the Korea Exchange regarding significant market fluctuations (unconfirmed status). It is a standard regulatory disclosure filing in Korea, which does not fit into specific categories like financial reports, dividends, or M&A. Therefore, it falls under the 'Regulatory Filings' (RNS) category as the fallback classification.
2021-04-02 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and dividend decisions. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2021-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to specific employees and executives, including the purpose, exercise price, and valuation methodology. This type of disclosure regarding the issuance of new equity-based incentives falls under the category of share capital changes or issuance announcements, which is best classified as 'SHA' (Share Issue/Capital Change).
2021-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.